Skip to content

Application of anticoagulation Decision-Making and management model based on the 'I-Anticoagulation' in patients with atrial fibrillation: a prospective, multicenter, cluster randomized controlled study

Application of anticoagulation Decision-Making and management model based on the 'I-Anticoagulation' in patients with atrial fibrillation: a prospective, multicenter, cluster randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062123
Enrollment
Unknown
Registered
2022-07-23
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Intervention Group:Anticoagulation management for patients using the I-Anticoagulation applet
Control group:Usual care without intervention

Sponsors

Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >18 years old; 2.Patients diagnosed with new-onset, paroxysmal, persistent or permanent atrial fibrillation by ECG or 24-hour Holter monitoring; 3.Patients or guardians agreed to the research plan and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1.Active bleeding 2.History of intracranial hemorrhage 3.Gastrointestinal bleeding within 12 months prior to randomization 4.Severe hepatic and renal insufficiency 5.Pregnant or lactating women 6.Any situation in which the investigator determines that the subject is not suitable for anticoagulant therapy 7.Known allergy or intolerance to oral anticoagulants

Design outcomes

Primary

MeasureTime frame
Incidence of bleeding events at 1-year follow-up;the accordance of stroke prophylaxis for AF according to current guidelines;the percentage of time in the target INR range (TTR) for patients using warfarin;the occurrence of minor bleeding events;

Countries

China

Contacts

Public ContactGu Zhichun
mangmang0400@163.com+86 13917839479

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026